Academic Journals Database
Disseminating quality controlled scientific knowledge

Search Articles for "imatinib"

ADD TO MY LIST
 
Imatinib-induced pancreatitis

Author(s): Varma Mahesh | Mathew Shibi | Krishnadas Devadas | Vinayakumar K
Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)

Author(s): Koon Henry | Honda Kord | Lee Jeannette | Christner Susan | Egorin Merrill | Noy Ariela
Gastrointestinal stromal tumor of stomach with inguinal lymph nodes metastasis: A case report

Author(s): Qin Zhang, Ji-Wei Yu, Wei-Li Yang, Xiao-Sun Liu, Ji-Ren Yu
Molecular basis and management of gastrointestinal stromal tumors

Author(s): Ulas D Bayraktar, Soley Bayraktar, Caio M Rocha-Lima
Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors

Author(s): Caenepeel Sean | Renshaw-Gegg Lisa | Baher Angelo | Bush Tammy | Baron Will | Juan Todd | Manoukian Raffi | Tasker Andrew | Polverino Anthony | Hughes Paul
Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?

Author(s): Giovanni Martinelli | Simona Soverini | Ilaria Iacobucci | Cristina Papayannidis | Daniela Cilloni | Michele Baccarani
Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options

Author(s): Francesco Perri, Giuseppe Di Lorenzo, Giuseppina Della Vittoria Scarpati, Carlo Buonerba
Perforation of the colon by invading recurrent gastrointestinal stromal tumors during sunitinib treatment

Author(s): Hoon Hur, Ae Ryoung Park, Sung Bae Jee, Seung Eun Jung, Wook Kim, Hae Myung Jeon
Membranoproliferative glomerulonephritis secondary to chronic myeloid leukemia

Author(s): Subramanian Murali | Kilara Nalini | Manjunath R | Mysorekar Vijaya
Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy

Author(s): Zhenshu Xu | Shundong Cang | Ting Yang | Delong Liu
Periorbital edema secondary to imatinib mesylate

Author(s): Collin M McClelland | George J Harocopos | Philip L Custer
ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method

Author(s): Yücel Erbilgin | Suzin Çatal | Ahmet Emre Eşkazan | Özden Hatırnaz | Teoman Soysal | Uğur Özbek
Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model

Author(s): Li Minglun | Abdollahi Amir | Gröne Hermann-Josef | Lipson Kenneth | Belka Claus | Huber Peter
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors

Author(s): Seshadri Ramakrishnan | Rajendranath Rejiv
A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers

Author(s): Dunwell Thomas | Hesson Luke | Rauch Tibor | Wang Lihui | Clark Richard | Dallol Ashraf | Gentle Dean | Catchpoole Daniel | Maher Eamonn | Pfeifer Gerd | Latif Farida
Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients

Author(s): Ferraresi Virginia | Nuzzo Carmen | Zoccali Carmine | Marandino Ferdinando | Vidiri Antonello | Salducca Nicola | Zeuli Massimo | Giannarelli Diana | Cognetti Francesco | Biagini Roberto
Successful Peripheral Blood Stem Cells Collection in Imatinib Pretreated and Nilotinib-Treated Chronic Myeloid Leukemia Patient

Author(s): Samuel Vokurka | Vladimir Koza | Daniel Lysak | Michal Karas | Pavel Dvorak | Pavel Jindra | Marcela Hrabetova | Vera Vozobulova
A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis

Author(s): Jean-Emmanuel Kurtz | Irène Asmane | Anne-Claire Voegeli | Agnès Neuville | Armelle Dufresne | Valère Litique | Christine Chevreau | Jean-Pierre Bergerat
Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006

Author(s): Wang Ai-Hua | Wang Yan-Yan | Yao Yu | Xu Zi-Zhen | Zhou Li | Wang Li | Zhang Li | Chen Yu | Shen Zhi-Xiang | Hu Jiong | Li Jun-Min
WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE

Author(s): Miwako Narita, Masayoshi Masuko, Tohri Kurasaki, Toshiki Kitajima, Shoko Takenouchi, Anri Saitoh, Norihiro Watanabe, Tatsuo Furukawa, Ken Toba, Ichiro Fuse, Yoshifusa Aizawa, Manabu Kawakami, Yoshihiro Oka, Haruo Sugiyama, Masuhiro Takahashi
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

Author(s): Silva Mara | Veiga Isabel | Ribeiro Franclim | Vieira Joana | Pinto Carla | Pinheiro Manuela | Mesquita Bárbara | Santos Catarina | Soares Marta | Dinis José | Santos Lúcio | Lopes Paula | Afonso Mariana | Lopes Carlos | Teixeira Manuel
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts

Author(s): Haubeiss Silke | Schmid Jens | Mürdter Thomas | Sonnenberg Maike | Friedel Godehard | van der Kuip Heiko | Aulitzky Walter
Dramatic regression and bleeding of a duodenal GIST during preoperative imatinib therapy: case report and review

Author(s): Hecker Andreas | Hecker Birgit | Bassaly Birgit | Hirschburger Markus | Schwandner Thilo | Janßen Hermann | Padberg Winfried
Systemic treatment of chronic GVHD

Author(s): Michael Schleuning
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

Author(s): Merkelbach-Bruse Sabine | Dietmaier Wolfgang | Füzesi Laszlo | Gaumann Andreas | Haller Florian | Kitz Julia | Krohn Antje | Mechtersheimer Gunhild | Penzel Roland | Schildhaus Hans-Ulrich | Schneider-Stock Regine | Simon Ronald | Wardelmann Eva
The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire

Author(s): K. G. Koffi | D. C. Nanho | E. N'dathz | P. Kouehion | R. Dissieka | A. Attia | K. Mozard | A. Tolo | K. Boidy | N. Meité | R. Ayemou | M. Sekongo | N. Tea | I. Sanogo
MORPHOLOGICAL AND IMMUNOCYTOCHEMICAL CHARACTERISTICS OF STROMAL GASTROINTESTINAL TUMORS

Author(s): Vuka Katić | Boris Đinđić | Vesna Živković | Danica Marković | Bojana Marković- Živković | Ivan Ilić | Dušan Mihajlović
Gastrointestinal stromal tumors: A 7-year experience from a tertiary care hospital

Author(s): Lakshmi Vasantha | Chacko Raju | Kurian Susy
Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report

Author(s): Watanabe Koichiro | Otsu Satoshi | Morinaga Ryotaro | Kawano Sakura | Hirashima Yoshinori | Sakashita Hiroyuki | Shirao Kuniaki
Gastrointestinal stromal tumors (GIST) of the stomach as a cause of upper gastrointestinal bleeding

Author(s): Ebrahimi K. | Veličković D. | Špica B. | Sabljak P. | Bjelović M. | Stojakov D. | Micev M. | Dunjić M. | Peško P.
Update on management of GIST and postsurgical use of imatinib

Author(s): E Pennacchioli | C Colombo | M Berselli | et al
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

Author(s): Martin Henkes | Heiko van der Kuip | Walter E Aulitzky
Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance

Author(s): Jennifer S Carew | Steffan T Nawrocki | Francis J Giles | John L Cleveland
Development and targeted use of nilotinib in chronic myeloid leukemia

Author(s): Carmen Fava | Hagop Kantarjian | Jorge Cortes | Elias Jabbour
Targeted treatment of chronic myeloid leukemia: role of imatinib

Author(s): Ila Tamascar | Jeyanthi Ramanarayanan
Dasatinib in chronic myeloid leukemia: a review

Author(s): Dolly G Aguilera | Apostolia M Tsimberidou
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib

Author(s): Ronan Swords | Devalingam Mahalingam | Swaminathan Padmanabhan | Jennifer Carew | Francis Giles
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia

Author(s): Radhakrishnan Ramchandren | Charles A Schiffer
Multiple roles and therapeutic implications of Akt signaling in cancer

Author(s): Emiliano Calvo | Victoria Bolós | Enrique Grande
Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

Author(s): Elias Jabbour | Jorge Cortes | Hagop Kantarjian
BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance

Author(s): Quentmeier Hilmar | Eberth Sonja | Romani Julia | Zaborski Margarete | Drexler Hans
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET

Author(s): Pantaleo Maria | Nicoletti Giordano | Nanni Cristina | Gnocchi Chiara | Landuzzi Lorena | Quarta Carmelo | Boschi Stefano | Nannini Margherita | Di Battista Monica | Castellucci Paolo | Fanti Stefano | Lollini Pier | Bellan Elena | Castelli Mauro | Rubello Domenico | Biasco Guido
Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors

Author(s): Kegel Kimberly | Sapp Ellen | Alexander Jonathan | Reeves Patrick | Bleckmann Dorothee | Sobin Linsday | Masso Nicholas | Valencia Antonio | Jeong Hyunkyung | Krainc Dimitri | Palacino James | Curtis Daniel | Kuhn Rainer | Betschart Claudia | Sena-Esteves Miguel | Aronin Neil | Paganetti Paolo | DiFiglia Marian
Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor

Author(s): Kayastha Gyan | Gurung Padma | Acharya Paras | Paudyal Buddhi | Hayes Bruce | Zimmerman Mark | Karki Arjun | Mansfield Aaron
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib

Author(s): Wei Guoqing | Rafiyath Shamudheen | Liu Delong
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission

Author(s): Serpa Mariana | Sanabani Sabri | Dorliac-Llacer Pedro | Conchon Monika | Pereira Thales | Nardinelli Luciana | Costa Juliana | Novaes Mafalda | Ferreira Patricia | Bendit Israel
Malignant gastrointestinal stromal tumor presenting with hemoperitoneum in puerperium: report of a case with review of the literature

Author(s): Varras Michail | Vlachakos Nikolaos | Akrivis Christodoulos | Vasilakaki Thivi | Skafida Evangelia
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

Author(s): David L DeRemer | Katerina Katsanevas | Celalettin Ustun
Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor

Author(s): Ying-Yong Hou, Yang Zhou, Shao-Hua Lu, Wei-Dong Qi, Cheng Xu, Jun Hou, Yun-Shan Tan
Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate

Author(s): Sith Phongkitkarun, Cholada Phaisanphrukkun, Janjira Jatchavala, Ekaphop Sirachainan
Gastrointestinal stromal tumour of the rectum: Report of a case and review of literature

Author(s): Nello Grassi, Calogero Cipolla, Adriana Torcivia, Stefano Mandalà, Giuseppa Graceffa, Alessandro Bottino, Federica Latteri
Pathologic complete response confirmed by surgical resection for liver metastases of gastrointestinal stromal tumor after treatment with imatinib mesylate

Author(s): Seiji Suzuki, Koji Sasajima, Masayuki Miyamoto, Hidehiro Watanabe, Tadashi Yokoyama, Hiroshi Maruyama, Takeshi Matsutani, Aimin Liu, Masaru Hosone, Shotaro Maeda, Takashi Tajiri.
Gastrointestinal stromal tumors: Thirty years experience of an Institution

Author(s): Simone Arolfo, Paolo Mello Teggia, Mario Nano
Three cases of bone metastases in patients with gastrointestinal stromal tumors

Author(s): Valerio Di Scioscio | Laura Greco | Maria Caterina Pallotti | Maria Abbondanza Pantaleo | Alessandra Maleddu | Margherita Nannini | Alberto Bazzocchi | Monica Di Battista | Anna Mandrioli | Cristian Lolli | Maristella Saponara | Giorgio Garzillo | Guido Biasco | Maurizio Zompatori
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

Author(s): Blesius Aurore | Cassier Philippe | Bertucci François | Fayette Jerome | Ray-Coquard Isabelle | Bui Binh | Adenis Antoine | Rios Maria | Cupissol Didier | Pérol David | Blay Jean-Yves | Le Cesne Axel
Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance

Author(s): Yen-Yang Chen | Chun-Nan Yeh | Chi-Tung Cheng | Tsung-Wen Chen | Kun-Ming Rau | Yi-Yin Jan | Miin-Fu Chen
Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic Cancer

Author(s): Michio Abe | Zbigniew P. Kortylewicz | Charles A. Enke | Elizabeth Mack | Janina Baranowska-Kortylewicz
Leczenie chirurgiczne nowotworów podścieliskowych przewodu pokarmowego

Author(s): Dorota Mrozowska | Wiktor Bednarz | Jan Cader | Leszek Paradowski | Zbigniew Krawczyk | Janusz Dawiskiba
Leczenie chirurgiczne nowotworów podścieliskowych przewodu pokarmowego (GIST)

Author(s): Włodzimierz Ruka | Piotr Rutkowski | Marcin Zdzienicki | Zbigniew I. Nowecki
Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation

Author(s): B. Uz | O. Bektas | E. Eliacık | H. Goker | Y. Erbilgin | M. Sayitoglu | N. Sayinalp | S. Aksu | Y. Buyukasik | O. Ozcebe | I. C. Haznedaroglu
Laparoscopic resection of gastric gastrointestinal stromal tumors presenting as left adrenal tumors

Author(s): Shiu-Dong Chung | Jeff Shih-chieh Chueh | Hong-Jeng Yu
A Rare t(9;22;16)(q34;q11;q24) Translocation in Chronic Myeloid Leukemia for Which Imatinib Mesylate Was Effective: A Case Report

Author(s): Masahiro Manabe | Yumi Yoshii | Satoru Mukai | Erina Sakamoto | Hiroshi Kanashima | Takeshi Inoue | Hirofumi Teshima
Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571)

Author(s): Elizabeth M. Pinder | Gurprit S. S. Atwal | Abraham A. Ayantunde | Sarah Khan | Mike Sokal | Tom McCulloch | Simon L. Parsons
Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?

Author(s): Avital F. Barak | Lilach Bonstein | Roy Lauterbach | Elizabeth Naparstek | Sigal Tavor
Radiotherapy in the treament of gastrointestinal stromal tumors

Author(s): Christin A. Knowlton | Luther W. Brady | Rebecca C. Heintzelman
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor

Author(s): Cristian Lolli | Maria Abbondanza Pantaleo | Margherita Nannini | Maristella Saponara | Maria Caterina Pallotti | Valerio Di Scioscio | Anna Mandrioli | Guido Biasco
Efficacy of imatinib dose escalation in Chinese gastrointestinal stromal tumor patients

Author(s): Jian Li | Ji-Fang Gong | Jie Li | Jing Gao | Nai-Ping Sun | Lin Shen
CML cell trafficking: Influence of the stromal microenvironment

Author(s): Ellen Weisberg | James D. Griffin
Tyrosine kinase inhibitors in hematological malignancies

Author(s): Kamila Kosior | Magdalena Lewandowska-Grygiel | Krzysztof Giannopoulos
Serious Skin Reaction Associated with Imatinib in a Patient with Chronic Myeloid Leukemia

Author(s): Murat Albayrak | Harika Celebi | Aynur Albayrak | Esra Saribacak Can | Vedat Aslan | Birgul Onec | Ipek Coban
Study of the role of

Author(s): Marco Tutone | Antonino Lauria | Anna Maria Almerico
Advances in the treatment of chronic myeloid leukemia

Author(s): Eiring Anna | Khorashad Jamshid | Morley Kimberly | Deininger Michael
Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy

Author(s): Da Riva Luca | Bozzi Fabio | Mondellini Piera | Miccichè Francesca | Fumagalli Elena | Vaghi Elena | Tarantino Eva | Huber Veronica | Gronchi Alessandro | Tamborini Elena | Pierotti Marco | Pilotti Silvana | Bongarzone Italia
Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review

Author(s): Launay Simon | Chetaille Bruno | Medina Fanny | Perrot Delphine | Nazarian Serge | Guiramand Jérôme | Moureau-Zabotto Laurence | Bertucci François
Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation

Author(s): Gueorgui Balatzenko | Nikolay Stoyanov | Elena Bekrieva | Margarita Guenova
Investigation of P16INK4A and P14RF Genes Expression in Different Phase of Chronic Myeloid Leukemia (CML)

Author(s): SH Mousavi | Y Mortazavi | H Dargahi | N Shayan | K Alimoghadam | A Ghavamzadeh | M Iravani | SA Mousavi | SH Ghaffari
Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia

Author(s): Gholamreza Bahoush | Mardavizh Albouyeh | Parvaneh Vossough
Non-Hodgkin's lymphoma in a chronic myelocytic leukemia patient treated with imatinib

Author(s): Semra Paydaş | Berna Bozkurt Duman | Melek Ergin
Variant Philadelphia translocations with different breakpoints in six chronic myeloid leukemia patients

Author(s): Dilhan Kuru | Yelda Tarkan Argüden | Muhlis Cem Ar | Ayşe Çırakoğlu | Şeniz Öngören | Şükriye Yılmaz | Ahmet Emre Eşkazan | Ayhan Deviren | Teoman Soysal | Seniha Hacıhanefioğlu | Birsen Ülkü
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

Author(s): Massimo Breccia | Corrado Girmenia | Roberto Latagliata | Giuseppina Loglisci | Michelina Santopietro | Vincenzo Federico | Luigi Petrucci | Alessandra Serrao | Adriano Salaroli | Giuliana Alimena
Identification of novel target genes of nerve growth factor (NGF) in human mastocytoma cell line (HMC-1 (V560G c-Kit)) by transcriptome analysis

Author(s): Dutta Priyanka | Koch Alexandra | Breyer Bjoern | Schneider Heike | Dittrich-Breiholz Oliver | Kracht Michael | Tamura Teruko
Gastrointestinal Stromal Tumours treated before and after the advent of c-kit immunostaining

Author(s): Sorelli Paolo | Cohen Patrizia | Amo-Takyi Bafour | Theodorou Nikitas | Dawson Peter
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells

Author(s): Cavalieri Elisabetta | Rigo Antonella | Bonifacio Massimiliano | de Prati Alessandra | Guardalben Emanuele | Bergamini Christian | Fato Romana | Pizzolo Giovanni | Suzuki Hisanori | Vinante Fabrizio
Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report

Author(s): Shimabukuro-Vornhagen Alexander | Rothe Achim | Nogova Lucia | Kochanek Matthias | Scheid Christoph | von Bergwelt-Baildon Michael
Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

Author(s): Hennigs Jan | Keller Gunhild | Baumann Hans | Honecker Friedemann | Kluge Stefan | Bokemeyer Carsten | Brümmendorf Tim | Klose Hans
Pathological complete response in advanced gastric stromal tumor after imatinib mesylate therapy: a case report

Author(s): El Mesbahi Omar | Brahmi Sami | Akasbi Yousra | El Mrabet Fatima | Touyar Anas | Ossaden Abdelmalek | Znati Kaoutar | Maazaz Khalid | Amarti Affaf | Tizniti Siham | Taleb Khalid | Ibrahimi Adil
Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine

Author(s): Erguven Mine | Bilir Ayhan | Yazihan Nuray | Ermis Ezgi | Sabanci Akin | Aktas Esin | Aras Yavuz | Alpman Vehbi
Chronic myeloid leukemia: past, present, future

Author(s): Patricia Weinschenker Bollmann | Auro del Giglio
Why do you need a reservation system?      Affiliate Program